Gene · 2250
Papers1,455
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,455
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Measured and genetically predicted protein levels and cardiovascular diseases in UK Biobank and China Kadoorie Biobank. | Nat Cardiovasc Res | 2024 | 39322770 | PubTator, text mining | PubMed |
| Fibroblast growth factor 5: A novel and promising therapeutic target in atrial fibrillation. | Int J Cardiol | 2024 | 39306291 | PubTator, text mining | PubMed |
| FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review). | Int J Oncol | 2024 | 39219285 | PubTator, text mining | PubMed |
| Boolean Modeling of Biological Network Applied to Protein-Protein Interaction Network of Autism Patients. | Biology (Basel) | 2024 | 39194544 | PubTator, text mining | PubMed |
| Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia. | Circ Genom Precis Med | 2024 | 39119725 | PubTator, text mining | PubMed |
| Fibroblast growth factor 5 as a target for atrial fibrillation treatment: Evidence from mendelian randomization. | Int J Cardiol | 2024 | 39059473 | PubTator, text mining | PubMed |
| Genetically predicted inflammatory proteins and the risk of atrial fibrillation: a bidirectional Mendelian randomization study. | Front Cardiovasc Med | 2024 | 38988665 | PubTator, text mining | PubMed |
| Circulating inflammatory cytokines influencing schizophrenia: a Mendelian randomization study. | Front Psychiatry | 2024 | 38979494 | PubTator, text mining | PubMed |
| Effect of glucocorticoids for the management of immune-related adverse events on outcome in melanoma patients treated with immunotherapy-a retrospective and biomarker study. | Immunooncol Technol | 2024 | 38952418 | PubTator, text mining | PubMed |
| Real-life hypoglycaemia partially blunts the inflammatory response to experimental hypoglycaemia in people with type 1 diabetes. | Diabetes Obes Metab | 2024 | 38899554 | PubTator, text mining | PubMed |
| Identification of novel therapeutic targets for chronic kidney disease and kidney function by integrating multi-omics proteome with transcriptome. | Genome Med | 2024 | 38898508 | PubTator, text mining | PubMed |
| Causal Relationships Between Circulating Inflammatory Proteins and Obstructive Sleep Apnea: A Bidirectional Mendelian Randomization Study. | Nat Sci Sleep | 2024 | 38894977 | PubTator, text mining | PubMed |
| Multi-Omic Analysis Reveals Genetic Determinants and Therapeutic Targets of Chronic Kidney Disease and Kidney Function. | Int J Mol Sci | 2024 | 38892221 | PubTator, text mining | PubMed |
| Evidence supported by Mendelian randomization: impact on inflammatory factors in knee osteoarthritis. | Front Med (Lausanne) | 2024 | 38863887 | PubTator, text mining | PubMed |
| Identification of cytokines in benign and malignant thymus tumors: based on Mendelian randomization and proteomics. | Front Endocrinol (Lausanne) | 2024 | 38828408 | PubTator, text mining | PubMed |
| Inflammatory proteins mediate male erectile dysfunction via plasma metabolites. | Sex Med | 2024 | 38827362 | PubTator, text mining | PubMed |
| Adaptor protein 14-3-3zeta promotes corneal wound healing via regulating cell homeostasis, a potential novel therapy for corneal injury. | Exp Eye Res | 2024 | 38815790 | PubTator, text mining | PubMed |
| Inflammatory cytokines and their potential role in kidney stone disease: a Mendelian randomization study. | Int Urol Nephrol | 2024 | 38776057 | PubTator, text mining | PubMed |
| Integrative analysis of Iso-Seq and RNA-seq data reveals transcriptome complexity and differential isoform in skin tissues of different hair length Yak. | BMC Genomics | 2024 | 38773419 | PubTator, text mining | PubMed |
| Deciphering the role of CX3CL1-CX3CR1 in aortic aneurysm pathogenesis: insights from Mendelian randomization and transcriptomic analyses. | Front Immunol | 2024 | 38715600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2250/papers?page=5